JPM Brand Name


Generic Name

Sodium Alendronate


Osteoporosis Drugs


Treatment and prevention of osteoporosis in postmenopausal women

For the treatment of osteoporosis, DROLATE increases bone mass and reduces the incidence of fractures, including those of the hip and spine ( vertebral compression fractures).

For the prevention of osteoporosis, DROLATE may be considered in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of future fracture.

Treatment to increase bone mass in men with osteoporosis.

Treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density.

Treatment of Paget's disease of bone in men and women having alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.


Available Doses

5mg, 10mg, 35mg & 70mg.